Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

    The CEBRA grant funds innovative research to advance understanding and treatment of substance use disorders by supporting high-risk, high-impact projects.

    OverviewSimilar Grants
    OverviewSimilar Grants

    NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

    Support for early career researchers in hearing, balance, and speech aims to generate preliminary data for future individual research grants.

    HHS-NIH11Due Feb 17, 2027

    Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

    NIH supports exploratory, phased clinical research on the neurobiological mechanisms of substance use disorders, including relevant circuitry and behavior; clinical trials are optional.

    HHS-NIH11Due Feb 19, 2027

    Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

    Supports high-risk, high-impact research on HIV and substance use to advance HIV prevention, diagnosis, treatment, and virus suppression among people who use substances or have substance use disorders.

    HHS-NIH11Due Sep 25, 2027$3,500,000

    NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science

    This grant supports early stage investigators proposing innovative, high-risk research on the biological and behavioral mechanisms underlying substance use disorders.

    HHS-NIH11Forecasted May 26, 2027$375,000Forecasted

    NCMRR Early Career Research Award (R03 Clinical Trial Optional)

    The NCMRR Early Career Research Award supports rehabilitation scientists in establishing research careers towards subsequent R01 application.

    HHS-NIH11Due Feb 16, 2027$200,000